STEVENS CAPITAL MANAGEMENT LP - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 129 filers reported holding GW PHARMACEUTICALS PLC in Q2 2016. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2018$225,000
-32.4%
2,311
-21.7%
0.01%
-7.7%
Q1 2018$333,000
-12.6%
2,953
-6.2%
0.01%
-7.1%
Q1 2017$381,000
+37.5%
3,148
+4.1%
0.01%
+27.3%
Q2 2016$277,000
-13.7%
3,025
-14.1%
0.01%0.0%
Q1 2015$321,000
+9.2%
3,521
-18.8%
0.01%
+10.0%
Q4 2014$294,0004,3380.01%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2016
NameSharesValueWeighting ↓
Lamond Capital Partners LLC 134,230$9,085,0005.95%
VHCP Management, LLC 311,853$21,106,0005.81%
Iguana Healthcare Management, LLC 60,000$4,061,0001.96%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 366,187$24,784,0000.95%
ACUTA CAPITAL PARTNERS, LLC 20,000$1,354,0000.92%
United Asset Strategies, Inc. 14,278$966,0000.41%
PRUDENTIAL PLC 823,408$55,728,0000.24%
Rock Springs Capital Management LP 28,000$1,895,0000.22%
CLOUGH CAPITAL PARTNERS L P 84,600$5,726,0000.20%
Eventide Asset Management 25,000$1,692,0000.18%
View complete list of GW PHARMACEUTICALS PLC shareholders